AJR Live Webinars feature leading experts discussing some of AJR’s most cutting-edge articles—broadcasted each month live, online, with CME.

Miss a broadcast? You can still watch past webinars and earn credit.

Past AJR Live Webinars

Upcoming Webinars

Artificial Intelligence in Nuclear Medicine

June 19, 2024

Broadcasted Live and Online 12:00 noon–1:00 pm, Eastern Time 
Moderator: Heather Jacene, MD
Speakers: Munir Ghesani, MD and Eliot Siegel, MD

Nuclear medicine has historically taken the lead as an early adopter of hardware and software. Exciting new advances are underway using artificial intelligence (AI) to improve image quality, decrease radiation dose, reduce imaging time, allow lesion-to-lesion change assessment in temporal imaging, quantify global disease burden, aid in radiopharmaceutical therapy planning, and more. Is AI in nuclear medicine a game-changer? How has it already impacted the field, and what does the future hold?

In this webinar, AJR authors Munir Ghesani, MD, and Eliot Siegel, MD, will detail the present state of AI in nuclear medicine, addressing their respective points and counterpoints for the future.

Register Now

Learning Outcomes

  1. Review the current state of AI in nuclear medicine.
  2. Discuss potential future uses of AI in nuclear medicine.

AI Evaluation of Hepatic Steatosis on CT

July 17, 2024

Broadcasted Live and Online 12:00 noon–1:00 pm, Eastern Time 
Moderator: Federica Vernuccio, MD, PhD
Speaker: Perry Pickhardt, MD

Metabolic dysfunction-associated steatotic liver disease, defined by the presence of liver steatosis together with at least one out of five cardiometabolic factors, is the most common cause of chronic liver disease worldwide. The diagnosis of steatosis, therefore, represents both a global public health threat and a precision medicine challenge. The results of this AJR study are important for the early detection of liver steatosis using both a quantitative biomarker routinely used on contrast-enhanced CT and an artificial intelligence (AI) tool that could allow for large-scale opportunistic evaluation.

In this webinar, AJR author Perry J. Pickhardt, MD, (2002 Figley Fellow) will outline a practical approach for using CT to assess hepatic steatosis, including hints for reporting in clinical practice. Participants will also learn how to use an automated AI tool to accurately diagnose at least moderate hepatic steatosis on portal venous phase postcontrast CT.

Register Now

Learning Outcomes

  1. Outline a practical approach on the use of CT for the assessment of hepatic steatosis, with tips for clinical reporting.
  2. Learn how to use automated artificial intelligence AI tool to accurately diagnose at least moderate hepatic steatosis on portal venous phase postcontrast CT.
  3. Review findings for manually detecting at least moderate steatosis via quantitative biomarkers on portal venous phase postcontrast CT.
  4. Discuss the accuracy and integration of manual and automated measurement of hepatic steatosis on portal venous phase postcontrast CT for opportunistic screening at a population level.

The American Roentgen Ray Society (ARRS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.

The ARRS designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.